Pharmaceuticals, Biotechnology and Life Sciences
Additions strengthen management team and position company to advance portfolio of medicines targeting RNA-mediated diseases into the clinic SAN DIEGO–(BUSINESS…
Company Co-Founder and Chief Technology Officer Receives Distinguished Judith Stitt Best Abstract Award for Data Presented at the American Brachytherapy…
Findings will support application for European marketing authorization and augment body of data supporting efficacy and utility of its ready-to-use,…
Funding to support regulatory filing and pre-commercial planning for lead product candidate, inebilizumab, and to advance development of additional clinical…
− On Track to Report ILLUMINATE-A Topline Results in Late 2019 – − In Addition, Company Reports Final Positive Results…
– Special Meeting of Stockholders Adjourned Until July 12, 2019 BOSTON–(BUSINESS WIRE)–Flex Pharma, Inc. (Nasdaq: FLKS) today announced that approximately…
In CLL/SLL Patients in the DUO Study, Duvelisib Treatment Rapidly Increased Lymphocytes and Resulted in Shrinkage of Lymph Nodes, With…
LONDON–(BUSINESS WIRE)–#Biotechnology–The global bacterial disease diagnostics market is expected to post a CAGR of close to 6% during the period…
—Proposed acquisition strengthens Pfizer’s innovative biopharmaceutical business and is expected to accelerate its growth trajectory particularly in the long term…
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies…